Diversified Business ModelIAG's diversified investment model spans real estate, financial services and technology, creating multiple durable revenue sources (rent, management/performance fees, startup equity). Structural diversification reduces single-sector risk and gives optionality to reallocate capital across cycles.

Strategic Partnerships & JVsReported partnerships and joint ventures broaden IAG's deal flow, co-investment capacity and market access. Structurally, alliances allow sharing execution risk, sourcing larger projects and leveraging partner expertise, enabling scale without equivalent capital commitment.

Lean Operating FootprintA small employee base implies a lean operating footprint that helps keep fixed costs low and preserves capital for investment. For an investment company, lower overhead supports higher marginal returns on deployed capital and faster scaling of asset-management or startup positions.

Bears Say

Unprofitable OperationsFinancial statements indicate declining revenue and negative margins across gross, EBIT/EBITDA and net levels. Persistent unprofitability erodes retained capital, limits self-funding for growth, pressures margins long-term, and heightens the need for structural cost or business-model remediation.

Weak Cash GenerationNegative operating and free cash flow show the company is not generating cash from core activities. This restricts internal reinvestment, raises reliance on external financing, increases liquidity risk, and constrains the ability to sustain projects or support portfolio companies through cycles.

High Leverage & Declining EquityA high debt-to-equity ratio and falling equity weaken solvency and financial flexibility. Elevated leverage increases interest and refinancing risk, limits strategic options like acquisitions or capital deployment, and magnifies downside during revenue or cash-flow stress.

8513 FAQ

What was IAG Holdings Limited’s price range in the past 12 months?

IAG Holdings Limited lowest stock price was HK$0.58 and its highest was HK$1.85 in the past 12 months.

What is IAG Holdings Limited’s market cap?

IAG Holdings Limited’s market cap is HK$49.93M.

When is IAG Holdings Limited’s upcoming earnings report date?

IAG Holdings Limited’s upcoming earnings report date is Apr 01, 2026 which is in 37 days.

How were IAG Holdings Limited’s earnings last quarter?

Currently, no data Available

Is IAG Holdings Limited overvalued?

According to Wall Street analysts IAG Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does IAG Holdings Limited pay dividends?

IAG Holdings Limited does not currently pay dividends.

What is IAG Holdings Limited’s EPS estimate?

IAG Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does IAG Holdings Limited have?

IAG Holdings Limited has 81,845,535 shares outstanding.

What happened to IAG Holdings Limited’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of IAG Holdings Limited?

Currently, no hedge funds are holding shares in HK:8513

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

IAG Holdings Limited Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

-75.03%

Trailing 12-Months

Asset Growth

-6.03%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

IAG Holdings Limited

IAG Holdings Limited is an investment holding company mainly engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices. It also provides tooling services. Molded plastic parts include component parts, as well as assembly of plastic parts assembled into sub-assembly products. The injection molded plastic parts are made for a range of medical uses such as respiratory products, dialysis products, blood bag products, drug delivery products and diagnostic tools. Tooling services are the services provided for the fabrication of mold to be used in the injection molding process. The major consumers include multinational corporation (MNC) medical device companies from the United States, Europe and Japan.